ÂÜÀòÂÒÂ×

Tom Baladi is an accomplished scientist specializing in oligonucleotide chemistry with extensive experience in medicinal chemistry and organic synthesis. Currently serving as an Associate Principal Scientist and Senior Research Scientist at AstraZeneca since August 2020, Tom also co-founded LanteRNA in November 2021. Prior to these roles, Tom held postdoctoral fellowships at Chalmers University of Technology and Institut de Chimie de Nice, where work focused on developing fluorescent base analogues and designing small molecules for cancer treatment, respectively. Tom earned a PhD in Medicinal and Pharmaceutical Chemistry from Université Paris-Saclay and has a strong educational background in organic chemistry, with master's and bachelor's degrees from Ecole Nationale Supérieure de Chimie de Montpellier and Université Montpellier II.